Original Article

Incidence of Unlicensed and Off-Label Prescription in the Treatment of Urological Cancers in Turkey: Assessment of Legislative and Regulatory Policy

• Mehmet Hanifi Tanyeri
• Güvenç Koçkaya
• Mehmet Emin Büyükokuroğlu
• Pelin Tanyeri
• İsmail Mert Vural
• Saim Kerman

Frequency of Incidental Prostate Adenocarcinoma Detection in Patients with Radical Cystoprostatectomy for Bladder Urothelial Cancer and Research into the Need for PSA Monitoring for Local-systemic Recurrence

• Ahmet Selçuk Dindar
• Yüksel Yılmaz
• Yiğit Akın
• Osman Köse
• Sacit Nuri Görgel
• Serkan Özcan

Recurrence Rate of Primary Superficial Bladder Tumors (Uroepithelial Tumors) at 2-Year Follow-up and Its Relationship with Smoking

• Bilal Çetin
• Osman Köse
• Ünsal Özkuvancı
• Yüksel Yılmaz

Non-urothelial Bladder Cancers: Single Center Experience

• Abdullah Sakin
• Şaban Seçmeler
• Serdar Arıcı
• Orçun Can
• Çağlayan Geredeli
• Nurgül Yaşar
• Cumhur Demir

Effect of COVID-19 Pandemic on Diagnosis and Treatment Delays in Primary Bladder Cancer in Turkey: Single-Institution Experience, 36 Month Screening

• Recep Burak Değirmentepe
• Yasir Muhammed Akça
• Hasan Salih Köse
• Kemal Demirhan
• Fikret Halis
• Ahmet Gökçe

Case Report

A Case of Incidentally Detected Endometrial Cancer After Surgery of Urothelial Cell Bladder Carcinoma

• Vedat Uğurel
• İsmail Bıyık
• Mehmet Musa Aslan